www.illumina.com
Open in
urlscan Pro
99.81.182.73
Public Scan
Submitted URL: https://beckershealthcare-news.com/portal/wts/uc%5EcnkmcDVqbaPvxa8nFoqjtssnCf
Effective URL: https://www.illumina.com/?utm_medium=email&utm_content=newsletter
Submission: On August 29 via api from US — Scanned from DE
Effective URL: https://www.illumina.com/?utm_medium=email&utm_content=newsletter
Submission: On August 29 via api from US — Scanned from DE
Form analysis
0 forms found in the DOMText Content
Products Learn Company Support Products * Instruments * Kits & Reagents * Selection Tools * Software & Analysis * Services * Popular Products Explore All Products Instruments * Sequencing Platforms * Microarray Scanners * IVD Instruments All Instruments DREAM BIG. NOVASEQ X CAN MAKE IT HAPPEN. Learn More Kits & Reagents * Library Preparation Kits * Sequencing Reagents * Microarray Kits * Clinical Research Products * IVD Products All Kits & Reagents ANNOUNCING ILLUMINA COMPLETE LONG READS Illumina Complete Long Read technology enables both long and short reads on the same NovaSeq instrument Learn More Selection Tools * Library Prep & Array Kit Selector * Gene Panel & Array Finder * Sequencer Comparison Tool * DesignStudio Custom Assay Designer * TruSight Oncology 500 Product Selector All Selection & Planning Tools TRUSIGHT ONCOLOGY 500 SELECTION TOOL Filter by batch size, system, software, and more. Compare and cart products. Find the Right Kit Software & Analysis * BaseSpace Sequence Hub * DRAGEN Secondary Analysis * Illumina Connected Analytics * Emedgene * Illumina Connected Insights * Clarity LIMS * Correlation Engine * Microarray Software All Software & Informatics Products DRAGEN V4.2 New features include increased SNV and SV calling accuracy, improvements in small CNV calling accuracy, and new targeted callers Learn More Services * Sequencing Services * Microarray Services * Proactive Instrument Monitoring * Instrument Services & Training All Services ILLUMINA PROACTIVE INSTRUMENT PERFORMANCE SERVICE Our instrument performance service helps reduce unplanned downtime and minimize instrument requalification Learn More Popular Products * AmpliSeq for Illumina * Illumina Complete Long Reads * COVIDSeq Assay (96 samples) * Illumina DNA Prep * Illumina RNA Prep with Enrichment * NextSeq 1000 & 2000 Sequencing Systems * TruSight Oncology Product Family All Popular Products NEW NEXTSEQ 1000/2000 P1 AND P2 600-CYCLE KITS New configurations will bring longer read capabilities with more output for immune repertoire, shotgun metagenomics and more Order Now Learn * Areas of Interest * Techniques * Technology * Illumina Research & Innovation * Training * Publications * Data Analysis & Informatics See All Learning Options Areas of Interest Research Applications * Cancer Research * Microbiology * Agrigenomics * Complex Disease Genomics * Cellular & Molecular Biology Clinical Applications * Reproductive Health * Oncology * Genetic & Rare Diseases All Areas LEARNING ABOUT OUR OWN GENOMES THROUGH PRIMATES A new algorithm trained by natural selection can pinpoint disease-causing variants in humans Learn More Techniques Sequencing * DNA Sequencing * RNA Sequencing * High-Throughput Sequencing * Library Preparation Microarrays Popular Genomics Applications * Genotyping * Gene Expression Analysis * Epigenetics * Genome Editing * Multiomics All Techniques LEARNING ABOUT OUR OWN GENOMES THROUGH PRIMATES A new algorithm trained by natural selection can pinpoint disease-causing variants in humans Learn More Technology NGS for Beginners Our Technologies * Next-Generation Sequencing * Long-Read Sequencing * Microarray Technology Sequencing Method Explorer All Technologies LEARNING ABOUT OUR OWN GENOMES THROUGH PRIMATES A new algorithm trained by natural selection can pinpoint disease-causing variants in humans Learn More Illumina Research & Innovation Genomics Research Hub * Genomics Articles * Illumina Publications * Open-Source Bioinformatics Tools LEARNING ABOUT OUR OWN GENOMES THROUGH PRIMATES A new algorithm trained by natural selection can pinpoint disease-causing variants in humans Learn More Training Illumina Resources & Tools NGS for Beginners Genomics Education * Illumina NGS & Array Training * Educational Webinars * Support Webinars & Online Training * Videos * Podcasts Medical Genetics All Training LEARNING ABOUT OUR OWN GENOMES THROUGH PRIMATES A new algorithm trained by natural selection can pinpoint disease-causing variants in humans Learn More Publications Peer-Reviewed Publications * Illumina Publications * Publication Summaries Customer Stories * iCommunity Interviews * Customer Videos * More Stories LEARNING ABOUT OUR OWN GENOMES THROUGH PRIMATES A new algorithm trained by natural selection can pinpoint disease-causing variants in humans Learn More Data Analysis & Informatics Infrastructure & Pipeline Setup Sequencing Data Analysis Biological Data Interpretation All Informatics Education LEARNING ABOUT OUR OWN GENOMES THROUGH PRIMATES A new algorithm trained by natural selection can pinpoint disease-causing variants in humans Learn More Company * About Us * News & Events * Careers * Corporate Social Responsibility * Investor Info * Doing Business With Us * Legal See All Company Info About Us * Office Locations * Management Team * Board of Directors * Ethics Advisory Board * Fact Sheet * iHope Philanthropic Sequencing * Governance & Code of Conduct More About Us 25 YEARS OF INNOVATION Our mission is to improve human health by unlocking the power of the genome Learn More News & Events News Center * Feature Articles * Perspectives Blog * Press Releases * Illumina in the News * Illumina Images Events & Webinars * Illumina Genomics Forum 25 YEARS OF INNOVATION Our mission is to improve human health by unlocking the power of the genome Learn More Careers * Overview * Search Jobs * Career Tracks * Employee Stories * Illumina Locations & Benefits More Career Info 25 YEARS OF INNOVATION Our mission is to improve human health by unlocking the power of the genome Learn More Corporate Social Responsibility * Overview * Accelerate Access to Genomics * Empower Our Communities * Integrate Sustainability * Nurture Our People * Advance Diversity, Equity, & Inclusion * Operate Responsibly * ESG Hub 25 YEARS OF INNOVATION Our mission is to improve human health by unlocking the power of the genome Learn More Investor Info * Overview * Shareholder Events * Financial Information * Stock Information * Corporate Governance All Investor Information 25 YEARS OF INNOVATION Our mission is to improve human health by unlocking the power of the genome Learn More Doing Business With Us * MyIllumina Customer Dashboard * Financial Solutions * Instrument Buying Options * Distributors * Suppliers * Illumina for Startups * Partnerships * Contact Us More Business Solutions 25 YEARS OF INNOVATION Our mission is to improve human health by unlocking the power of the genome Learn More Legal * Terms & Conditions * Report a Compliance Issue * Privacy * Governance & Code of Conduct All Legal Information 25 YEARS OF INNOVATION Our mission is to improve human health by unlocking the power of the genome Learn More Support * Product Support * Documents and Training * Tools * Services * Additional Resources * Contact & Medical Info View All Support Product Support * Instrument Support * Library Prep Kit Support * Microarray Support * Software Support ILLUMINA DRAGEN SECONDARY ANALYSIS V4.2 Get instructions for using DRAGEN Secondary Analysis v4.2 Learn More Documents and Training * Documentation * Technical Bulletins * Illumina Adapter Sequences * Support Webinars & Online Training * Instructor-Led & Other Training ILLUMINA DRAGEN SECONDARY ANALYSIS V4.2 Get instructions for using DRAGEN Secondary Analysis v4.2 Learn More Tools * Sequencing Coverage Calculator * Custom Protocol Selector * Library Prep & Array Kit Selector * Gene Panel and Array Finder All Support Tools ILLUMINA DRAGEN SECONDARY ANALYSIS V4.2 Get instructions for using DRAGEN Secondary Analysis v4.2 Learn More Services * Proactive Instrument Monitoring * Qualification Services All Product Support Services ILLUMINA DRAGEN SECONDARY ANALYSIS V4.2 Get instructions for using DRAGEN Secondary Analysis v4.2 Learn More Additional Resources * Certificates (CofC, CofA) and Master Lot Sheets * Safety Data Sheets * Share Desktop ILLUMINA DRAGEN SECONDARY ANALYSIS V4.2 Get instructions for using DRAGEN Secondary Analysis v4.2 Learn More Contact Us * Distributors * Suppliers * Medical Information & Resources * All Contact Info ILLUMINA DRAGEN SECONDARY ANALYSIS V4.2 Get instructions for using DRAGEN Secondary Analysis v4.2 Learn More 25 YEARS OF INNOVATION OUR MISSION IS TO IMPROVE HUMAN HEALTH BY UNLOCKING THE POWER OF THE GENOME. WE BELIEVE THAT, TOGETHER, WE CAN USE GENOMICS TO BUILD A STRONGER WORLD FOR THE GREATER GOOD. Learn More RESEARCH Cancer Microbiology Agrigenomics Complex Disease Cellular and Molecular Biology CLINICAL Reproductive Health Genetic & Rare Diseases Oncology Explore Areas of Interest * Cancer Research * Microbiology * Agrigenomics * Complex Disease * Cellular and Molecular Biology * Reproductive Health * Genetic & Rare Diseases * Clinical Oncology CUSTOMER INTERVIEW EFFICIENT CLOUD DATA ANALYSIS FOR COPD MULTIOMICS PROJECT Researchers at Okayama University in Japan use Illumina Connected Analytics with DRAGEN pipelines for analyzing whole-genome, exome, transcriptome,... Read Article CUSTOMER INTERVIEW USING ANALYTICS TO IMPROVE CANCER DIAGNOSIS Developing and automating workflows for analyzing, processing, and sharing genomic data among researchers and clinicians. Read Article CUSTOMER VIDEOS CUSTOMER EXPERIENCE WITH THE NEXTSEQ™ 2000 IN HUNGARY Dr Csaba Bodor, of Semmelweis University in Hungary brought a NextSeq™ 2000 into his lab to support the increasing throughput of his laboratory,... View Video x CUSTOMER EXPERIENCE WITH THE NEXTSEQ™ 2000 IN HUNGARY See More Interviews See More Videos CORE TECHNOLOGY SEQUENCING See what sequencing can do for you Learn MoreCompare Sequencers CORE TECHNOLOGY MICROARRAYS Analyze genetic variation on any scale Learn MoreCompare Array Scanners See All Instruments ANNOUNCING ILLUMINA COMPLETE LONG READS Illumina Complete Long Read technology enables both long and short reads on the same NovaSeq instrument. Learn More DREAM BIG. NOVASEQ X CAN MAKE IT HAPPEN. Learn More ACCELERATED DISCOVERY. EASIER THAN EVER. Unlock a broad range of applications with NextSeq 1000 and NextSeq 2000 Systems Learn More EDUCATION AND WEBINARS Learn about the latest genomics discoveries by Illumina scientists, or find webinars and free courses to get the most out of your experiments Explore Discoveries View Webinars View Courses FEATURED TOOL TRUSIGHT ONCOLOGY 500 SELECTION TOOL Filter by batch size, system, software, and more. Compare and cart products. Find the Right Kit POPULAR TOOLS -------------------------------------------------------------------------------- * MYILLUMINA CUSTOMER DASHBOARD Sign In or Learn More * LIBRARY PREP AND ARRAY KIT SELECTOR Launch Tool * BASESPACE SEQUENCE HUB Sign In or Learn More * CUSTOM PROTOCOL SELECTOR Build Protocol * DESIGNSTUDIO CUSTOM ASSAY DESIGNER Sign In or Learn More -------------------------------------------------------------------------------- See More Tools FEATURED NEWS HOW GENETIC TECHNOLOGIES CAN EMPOWER MORE PEOPLE WITH INFORMATION In Australia, genetic counseling service Eugene aims to provide support and consistency of care to prospective parents Read Article * Press Releases * In the News Date Title Aug 28, 2023 Illumina To Webcast Upcoming Investor Conference Aug 17, 2023 Illumina expands genomics capabilities in India with opening of Solutions Center Aug 11, 2023 Illumina To Webcast Upcoming Investor Conference View All Press Releases Date Publication Title Jul 26, 2023 Medical Device Network Illumina and Pillar collaborate to commercialise oncology assays Jul 20, 2023 Biocompare Selecting the Right NGS Method Jul 19, 2023 Genetic Engineering and Biotechnology News Alliance for Genomic Discovery Announces Five Founding Biopharma Members View All Illumina News EMPLOYEE STORY FOLLOW SUZANNE THROUGH HER TYPICAL DAY AS A BIOINFORMATICS SCIENTIST View Video View More Stories Search Jobs × FOLLOW SUZANNE THROUGH HER TYPICAL DAY AS A BIOINFORMATICS SCIENTIST   FOR RESEARCH USE ONLY Not for use in diagnostic procedures (except as specifically noted). Not for import or sale to the Australian general public. INNOVATIVE TECHNOLOGIES At Illumina, our goal is to apply innovative technologies to the analysis of genetic variation and function, making studies possible that were not even imaginable just a few years ago. It is mission critical for us to deliver innovative, flexible, and scalable solutions to meet the needs of our customers. As a global company that places high value on collaborative interactions, rapid delivery of solutions, and providing the highest level of quality, we strive to meet this challenge. Illumina innovative sequencing and array technologies are fueling groundbreaking advancements in life science research, translational and consumer genomics, and molecular diagnostics. ILLUMINA KOREA Hi Investment & Securities building 66 Yeoidaero Yeoungdeungpo-gu Seoul Korea 07325 * 02-740-5300 (tel) * 02-786-8368 (fax) * customercare@illumina.com 판매 약관 | Tax Reg: 105-87-87282 | Retailer Reg: 2019-서울영등포-2018 | Host: https://www.illumina.com | Address of host server location: 5200 Illumina Way, San Diego, CA 92122 U.S.A. All trademarks are the property of Illumina, Inc. or their respective owners. For specific trademark information, see www.illumina.com/company/legal.html. Cookie Settings Cookie Settings Privacy Policy Careers Contact Us © 2023 Illumina, Inc. All rights reserved. Feedback Accept cookies to provide feedback. × SEE MORE RELEVANT CONTENT. CHOOSE YOUR PRIMARY AREA OF INTEREST: × Cancer Research Microbiology Agrigenomics Complex Disease Clinical Oncology Reproductive Health Genetic & Rare Diseases Remove my preference COOKIE PREFERENCES Illumina, Inc. and its subdivisions use cookies to tailor website content and provide you with an optimal user experience. Select "Accept All Cookies” to get the most out of this site, or visit our Cookie Settings and allow specific types of cookies. Read our Cookie Policy to learn more. Accept Essential Cookies Only Accept All Cookies